TRADING UPDATES: Capital meets top end of view; Yu Group revenue rises
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 70.00p on 17-04-2026 at 17:10:05 |
|---|---|
| Change | 8.00p 12.9% |
| Buy | 75.00p |
| Sell | 65.00p |
| Last Trade: | Buy 1,290.00 at 71.50p |
| Day's Volume: | 274,693 |
| Last Close: | 70.00p |
| Open: | 62.00p |
| ISIN: | GB00B0BRN552 |
| Day's Range | 62.00p - 72.50p |
| 52wk Range: | 58.00p - 128.00p |
| Market Capitalisation: | £53.94m |
| VWAP: | 69.32777p |
| Shares in Issue: | 77.05m |
Sector: Software and Computing
Listed In: FTSE AIM All-Share,
Bango (BGO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1,290 | 71.50p | Ordinary |
16:28:52 - 17-Apr-26 |
| Buy* | 10,771 | 73.90p | Ordinary |
16:28:11 - 17-Apr-26 |
| Buy* | 904 | 71.45p | Ordinary |
15:46:16 - 17-Apr-26 |
| Buy* | 4,680 | 71.45p | Ordinary |
14:35:01 - 17-Apr-26 |
| Buy* | 20,000 | 71.36p | Ordinary |
14:17:18 - 17-Apr-26 |
| Buy* | 1,000 | 73.995p | Ordinary |
14:02:01 - 17-Apr-26 |
| Buy* | 250 | 73.995p | Ordinary |
13:59:58 - 17-Apr-26 |
| Buy* | 6,750 | 74.00p | Ordinary |
13:52:47 - 17-Apr-26 |
| Buy* | 5,000 | 71.355p | Ordinary |
13:22:58 - 17-Apr-26 |
| Buy* | 7,000 | 71.355p | Ordinary |
13:22:10 - 17-Apr-26 |
Bango (BGO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 7th Apr 2026 7:00 am | RNS | Notice of Results |
| 1st Apr 2026 9:15 am | RNS | Total Voting Rights |
| 20th Mar 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 10th Mar 2026 5:13 pm | RNS | Director/PDMR Shareholding |
| 10th Mar 2026 5:13 pm | RNS | Director/PDMR Shareholding |
| 2nd Mar 2026 7:00 am | RNS | Block Listing Six Monthly Return |
| 2nd Mar 2026 7:00 am | RNS | Total Voting Rights |
| 24th Feb 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 12th Feb 2026 3:43 pm | RNS | Director/PDMR Shareholding |
| 12th Feb 2026 11:29 am | RNS | Director/PDMR Shareholding |